| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27f751186333cc31f34627910b660ad7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0633 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-15003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-154 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-153 |
| filingDate |
2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50dbc93e34efaa65f0b2f0ac2210166d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62119cc4173829793f657125973a829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3faf368e26287952b2c2a5dd07a6717d |
| publicationDate |
2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017019552-A1 |
| titleOfInvention |
Blood sample optimization system and blood contaminant sequestration device and method |
| abstract |
Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device (1500) located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber (1508) for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel (1506) that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311219-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11653863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020527419-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617525-B2 |
| priorityDate |
2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |